BACKGROUND: Hereditary angioedema (HAE) is a rare disease characterized by unpredictable, painful swelling attacks. Social determinants of health may affect healthcare resource utilization (HCRU) for HAE attacks. OBJECTIVE: Estimate HCRU among patients with HAE analyzed by race and ethnicity, household income, and rural/urban residency. METHODS: This retrospective, observational study used healthcare insurance claims data (January 1, 2016, to September 30, 2023) from Inovalon's closed claims database. Eligible patients had a new HAE diagnosis or treatment claim (first claim defined index date), no previous claim in previous 12 months' continuous health plan enrollment, maintained 24-month continuous enrollment post-index, and were not using angiotensin-converting enzyme inhibitors. RESULTS: Multivariable models and HAE-related HCRU data revealed that patients from lower-income households (<$50,000 annually) had a higher risk of emergency department (ED) visits (risk ratio, 1.44; 95% confidence interval [95% CI], 1.23-1.68), but no difference in hospitalization risk (1.07; 95% CI, 0.69-1.65) versus those from higher-income households. Black patients had a higher risk of HAE-related ED visit (risk ratio, 1.50; 95% CI, 1.27-1.76), more ED visits (rate ratio, 2.33; 95% CI, 1.74-3.13), and higher hospitalization rates (2.25; 95% CI, 1.10-4.57) versus White patients. ED visit rate ratios were higher for Hispanic/Latino versus White patients (1.71; 95% CI, 1.16-2.50). Rural versus urban residency did not significantly affect HAE-related HCRU. Allergist/immunologist care access was lower among Black patients (16.7%) and among those from lower-income households (25.5%) versus the overall study population (27.5%). CONCLUSIONS: Among patients with HAE, disparities exist in HCRU. Targeted strategies are essential for ensuring equitable access and improving outcomes for underserved patients.